Home ›
Trademark Categories ›
Pharmaceuticals ›
2017 ›
CA ›
CAYARRA
Trademark search for:
CAYARRA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-01-27 — Application filed
2021-01-30 — Application filed
2021-04-29 — Application filed
2021-08-13 — Assigned to examiner
2021-08-20 — Approved for pub - principal register
2021-09-08 — Notification of notice of publication e-mailed
2021-09-28 — Published for opposition
2021-09-28 — Official gazette publication confirmation e-mailed
2021-10-26 — Extension of time to oppose received
2021-10-28 — Teas revoke/app/change addr of atty/dom rep received
2021-10-28 — Attorney/dom.rep.revoked and/or appointed
2021-10-28 — Teas withdrawal of attorney received-firm retains
2021-10-28 — Teas change of correspondence received
2021-12-02 — Teas post publication amendment received
2021-12-21 — Assigned to petition staff
2021-12-21 — Post publication amendment - entered
2022-02-06 — Extension of time to oppose process - terminated
2022-03-22 — Noa e-mailed - sou required from applicant
2022-09-15 — Sou teas extension received
2022-09-15 — Sou extension 1 filed
2022-09-15 — Sou extension 1 granted
2022-09-17 — Notice of approval of extension request e-mailed
2023-03-09 — Sou teas extension received
2023-03-09 — Sou extension 2 filed
2023-03-09 — Sou extension 2 granted
2023-03-11 — Notice of approval of extension request e-mailed
2023-09-14 — Sou extension 3 filed
2023-09-14 — Sou teas extension received
2023-09-14 — Sou extension 3 granted
2023-09-16 — Notice of approval of extension request e-mailed
2024-03-13 — Sou extension 4 filed
2024-03-13 — Sou teas extension received
2024-03-13 — Sou extension 4 granted
2024-03-14 — Notice of approval of extension request e-mailed
2024-08-27 — Sou teas extension received
2024-08-27 — Notice of approval of extension request e-mailed
2024-08-27 — Sou extension 5 filed
2024-08-27 — Sou extension 5 granted
2025-10-10 — Application abandoned
2025-10-10 — Application abandoned
2025-10-10 — Final status recorded
Owner Information
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc.
Correspondent
Laurence Rickles TEVA PHARMACEUTICALS USA, Inc.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
